Skip to main content

Market Overview

Elanco To Acquire Bayer's Animal Health Business For $7.6B

Share:
Elanco To Acquire Bayer's Animal Health Business For $7.6B

Elanco Animal Health Inc (NYSE: ELAN) shares were trading lower Tuesday after the company announced it would acquire Bayer AG (OTC: BAYRY)'s animal health business for $5.32 billion in cash and $2.28 billion in Elanco shares. The transaction is valued at $7.6 billion.

The deal is expected to double Elanco's companion animal business and create a balance between its food animal and companion animal segments.

"In our first four quarters as an independent company, we have validated the significant value creation potential from a dedicated focus on animal health and a targeted strategy," Elanco CEO Jeffrey Simmons said in a statement. 

"Joining Elanco and Bayer Animal Health strengthens and accelerates our IPP strategy, transforms our portfolio with the addition of well-known pet brands, brings an increased presence in key emerging markets, expands innovation and accelerates our margin expansion journey."

Elanco Animal Health shares were trading down 4.63% at $28.40 at the time of publication Tuesday. The stock has a 52-week high of $37.61 and a 52-week low of $28.

Related Links:

Estee Lauder Reports Q4 Earnings Beat, Raises Guidance

Weibo Trades Higher On Q2 Earnings Beat

 

Related Articles (BAYRY + ELAN)

View Comments and Join the Discussion!

Posted-In: M&A News Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com